pdufa.bio
Home › Decisions › ANIP 2026-04-08

ANIP FDA decision — Apr 8, 2026

✓ APPROVED

ANI Pharmaceuticals Inc. — Isosorbide Mononitrate Tablet USP (generic o · Angina attacks (chest pain)..

Run-up into the decision (T-120 → T+5)

PDUFA 4/8/26$95.38$70.4910/22/25
Daily close, T-120 (10/22/25) through T+5. Run-up high $95.38 on 10/29/25, low $70.49 on 3/16/26 (T-120 to T-1). FDA decision 4/8/26. Historical price action, not a forecast.

Key facts

FDA decision date2026-04-08
OutcomeApproved
Drug / candidateIsosorbide Mononitrate Tablet USP (generic o
CompanyANI Pharmaceuticals Inc.
120-day run-up (T-120→T-1)-10.4%
Not affiliated with or endorsed by the FDA. Informational and educational only — not investment advice. Verify against primary FDA / SEC / company filings. © 2026 pdufa.bio